Which angiosarcoma subtypes may benefit from immunotherapy?Stefan G. van Ravensteijn, Ingrid M.E. Desar, Melissa H.S. Hillebrandt-Roeffen et al.|Journal of Clinical Oncology|2022Cited by 2